Drugs / Vivigen
last change Jul 2018 re-read 2 minutes ago

Vivigen

Cell therapy

Developed for
vertebral column disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03527966 Comparator Jul 2017 → Jul 2018 vertebral column disorder Virtua Health, Inc. Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vivigen ClinicalTrials.gov intervention name — accepted as the source's own label NCT03527966
Modality Cell therapy “Vivigen, a novel cellular allograft product” NCT03527966